Novartis Lifts FullYear Sales and Profit Outlook Signaling Strong Operational Momentum Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Tensions Rise AIDriven Layoffs Market Reaction May Be Less Positive Than Expected Truist Raises Flywire Price Target After Strong Q1 Revenue Beat and Guidance Boost US CLARITY Act and Eastern Hubs How Western Crypto Regulation Could Shape Indias Financial Future Flipkart Sets Record with 200 Million SingleDay Sales Highest Since 2007 MCW Q1 2026 Earnings EPS Surges Past Estimates with 1444 Beat Stock Holds Steady Array Digital Infrastructure Inc UZE Q1 2026 Earnings Earnings Per Share Surges Past Estimates RYZ Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Operating Landscape TIMB Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement FELE Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Execution Sonida Senior Living SNDA Q1 2026 Earnings WiderThanExpected Loss Signals Persistent Operational Headwinds Reinsurance Group of America 575 FixedtoFloating Debentures RZB Edge Higher at 2529 Steady Yield Play Nears Key Resistance Cypherpunk Technologies CYPH Slides 8 Can Support at 101 Hold Home Federal Bancorp Inc HFBL Edges Higher in Modest Uptrend Brilliant Earth Group BRLT Jumps 4 Approaching Key Resistance at 137 Atlas Critical Minerals Corporation ATCX Edges Higher Amid Sector Momentum The Fed May Need to Raise Rates in July to Calm Bond Vigilantes Yardeni Warns LGL Group Q1 2026 Earnings Significant EPS Miss Marked by 11989 Surprise Lakeshore Acquisition III Corp Rights LCCCR Trading at Support as Momentum Remains Flat Ross Stores ROST Surges 72 Retail Resilience Boosts Sentiment HP Inc HPQ Faces Steep Decline as PC Market Headwinds Intensify FIGS Inc Edges Higher as Stock Approaches Resistance Zone HeartSciences Warrants HSCSW Remain Flat at 005 as Support and Resistance Coincide Title Cantor Equity Partners II Inc CEPT Slips 122 Consolidation Near Support as Traders Eye Key Levels Workiva WK Edges Lower Amid Sector Pressure Key Levels in Focus Kymera Therapeutics KYMR Retreats 148 as Stock Tests Key Support Level